Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma
Cells · 2024
DOI: 10.3390/cells14010006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Ibrahim Büdeyri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplant Surgery, University Hospital Muenster, University of Muenster, Albert-Schweitzer-Campus 1, 48149 Muens…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplastic Cells, Circulating, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rudolf Geißendörfer-Stiftung, Frankfurter Forschungsfoerderung, B. Braun-Stiftung.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer-related death worldwide, with no precise method for early detection. Circulating tumor cells (CTCs) expressing the dynamic polarity of the cytoskeletal membrane protein, ezrin, have been proposed to play a crucial role in tumor progression and metastasis. This study investigated the diagnostic and prognostic potential of polarized circulating tumor cells (p-CTCs) in HCC patients. CTCs were isolated from the peripheral blood of 20 HCC patients and 18 patients with nonmalignant liver disease (NMLD) via an OncoQuick® kit and immunostained with Ezrin-Alexa Fluor 488®, CD146-PE, and CD45-APC. A fluorescence microscopy was then performed for analysis. The HCC group exhibited significantly higher levels of p-CTCs, with median values of 0.56 p-CTCs/mL, compared to 0.02 p-CTCs/mL (p = 0.03) in the NMLD group. CTCs were detected in 95% of the HCC patients, with a sensitivity of 95% and specificity of 89%. p-CTCs were present in 75% of the HCC patients, with a sensitivity of 75% and a specificity of 94%. Higher p-CTC counts were associated with the significantly longer overall survival in HCC patients (p = 0.05). These findings suggest that p-CTCs could serve as valuable diagnostic and prognostic markers for HCC. The incorporation of p-CTCs into diagnostic strategies could enhance therapeutic decision-making and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General, Visceral and Transplant Surgery, University Hospital Muenster, University of Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
- Department of General, Visceral and Transplant Surgery, Frankfurt University Hospital, 60596 Frankfurt, Germany.
- Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
- Department of Diagnostic and Interventional Radiology, Frankfurt University Hospital, Goethe University, 60596 Frankfurt, Germany.
- Department of Biomedicine, Aarhus University, 8200 Aarhus, Denmark.
- Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
ORCID-Profile: Ibrahim Büdeyri, Elsie Oppermann, Felix Becker, Benjamin Struecker, Thomas J Vogl, Mazen A Juratli
Förderung
- Rudolf Geißendörfer-Stiftung
- Frankfurter Forschungsfoerderung
- B. Braun-Stiftung
- Open Access Publication Fund of the University of Muenster
Zitieren
APA
Büdeyri, I., Guckelberger, O., Oppermann, E., Roy, D., Sliwinski, S., Becker, F., Struecker, B., Vogl, T. J., Pascher, A., Bechstein, W. O., Lorentzen, A., Heikenwalder, M., & Juratli, M. A. (2024). Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma. Cells. https://doi.org/10.3390/cells14010006
Vancouver
Büdeyri I, Guckelberger O, Oppermann E, Roy D, Sliwinski S, Becker F, et al. Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma. Cells. 2024. doi:10.3390/cells14010006
BibTeX
@article{Bdeyri2024,
author = {Büdeyri, Ibrahim and Guckelberger, Olaf and Oppermann, Elsie and Roy, Dhruvajyoti and Sliwinski, Svenja and Becker, Felix and Struecker, Benjamin and Vogl, Thomas J and Pascher, Andreas and Bechstein, Wolf O and Lorentzen, Anna and Heikenwalder, Mathias and Juratli, Mazen A},
title = {Ezrin Polarization as a Diagnostic Marker for Circulating Tumor Cells in Hepatocellular Carcinoma},
journal = {Cells},
year = {2024},
doi = {10.3390/cells14010006}
}
EUVIMED